https://doi.org/10.55788/9d0a4ce1
Artificial intelligence (AI)-driven teledermatology may offer a solution to the limited access to dermatologic care in some parts of Africa. Since access to smartphones is high and internet connections are generally good, healthcare workers may improve their clinical decision-making skills with respect to skin disease through smartphone-guided teledermatology.
“The access to dermatologic care in [some parts of] Africa is very limited,” emphasised Mr Philippe Gottfrois (Basel University, Switzerland) [1]. “For example, to provide annual coverage for the entire population of Madagascar, dermatologists would have to see 5,200 patients per day.” Mr Gottfrois added that most healthcare workers are not trained in dermatology. “Also, dermatologists are mostly based in larger cities, leaving the rural areas uncovered. Fortunately, 57% of the population has a smartphone and the internet connection is generally good,” he said.
“Our AI-driven teledermatology project uses the high access to smartphones to offer teledermatology, in order to educate medical workers in managing common skin conditions,” said Mr Gottfrois. He explained that 5 conditions account for 80% of the consultations in Africa: dermatophytosis, insect bites, atopic dermatitis, scabies, and impetigo. Therapies are available for these conditions, and swift interventions can heal patients with these diseases efficiently.
The AI-teledermatology platform that is developed by Mr Gottfrois and colleagues begins with data collection by first healthcare providers. They take pictures of the skin condition and collect additional relevant patient information, which are then transferred via WhatsApp to a web-based app. This app will run an AI-driven diagnostic decision-making tool, informing the healthcare provider. He or she then decides whether there is a need to contact a dermatologist, who may provide feedback through telecommunication or whether the provided diagnosis by the app is sufficient.
Thus far, 1,400 cases of common skin diseases have been collected across Madagascar, Guinea, Tanzania, and Malawi, with an equal distribution of Fitzpatrick skin types 3 to 6. Pictures and additional data are added to the web app to create an AI-driven case atlas. The first results indicate that this approach has a sensitivity of 80% and a specificity of 85% with regard to detecting eczema. Further results are expected after the initiation of a clinical study in October 2023.
- Gottfrois P, et al. Passion project: AI driven teledermatology for common skin conditions in Africa. Session Teledermatology, WCD 2023, 3-8 July, Singapore.
© 2023 The Author(s). Published by Medicom Medical Publishers.
User license: Creative Commons Attribution – NonCommercial (CC BY-NC 4.0)
Posted on
« Oleogel-S10 shows long-term efficacy and safety in dystrophic epidermolysis bullosa Next Article
Large teledermatology project in a remote island in Eastern Indonesia »
Table of Contents: WCD 2023
Featured articles
Atopic Dermatitis
Rocatinlimab delivers efficacy and safety in atopic dermatitis
Head-to-head: paraffin- versus ceramide-based moisturiser for paediatric AD
Novel JAK1 inhibitor for patients with atopic dermatitis
Can lebrikizumab maintain response rates in atopic dermatitis?
Most patients with AD on dupilumab stick with this drug long-term
Psoriasis
Botulinum toxin A might provide efficacious treatment option for nail psoriasis
POETYK PSO-1 and 2: Long-term efficacy results of deucravacitinib in plaque psoriasis
Encouraging results for first oral IL-23 receptor antagonist in plaque psoriasis
Subcutaneous spesolimab for GPP flare prevention
Knocking out psoriasis with high-dose risankizumab?
Deucravacitinib versus other systemic therapies in Asian patients with psoriasis
Hair Disorders
Patients with AA report high long-term regrowth rates with baricitinib
Can ritlecitinib deliver long-term efficacy in alopecia areata?
TikTok videos on hair disorders lack reliability
Hidradenitis, Acne, and Rosacea
Spesolimab appears successful in hidradenitis suppurativa
Promising results for paroxetine in rosacea
Novel PPARγ modulator reduces acne manifestations
Microencapsulated benzoyl peroxide shifts skin microbiome in rosacea
Other Skin Conditions and Teledermatology
OLYMPIA 2: Positive results for nemolizumab in prurigo nodularis
PRFM or PRP therapy for trophic ulcers due to leprosy?
Large teledermatology project in a remote island in Eastern Indonesia
Can AI-driven teledermatology increase access to healthcare in rural African settings?
Oleogel-S10 shows long-term efficacy and safety in dystrophic epidermolysis bullosa
Picosecond alexandrite laser safe and effective in benign pigmentary disorders
Gentamicin improves symptoms in paediatric Nagashima-type palmoplantar keratosis
Related Articles

EADV 2020 Highlights Podcast

IL-17 blocker: effective and safe in patients with comorbidities
© 2023 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy